Search

To assess the utility of routine duplex surveillance, 379 infrainguinal reversed vein grafts performed at two independent teaching hospitals were prospectively entered into a surveillance protocol from March 1986 through August 1989. An average of 3.2 postoperative duplex graft flow velocity (GFV) measurements per graft was obtained during a mean follow-up interval of 21 1/2 months. Only 2.1% of 280 grafts with GFV measurements greater than 45 cm/sec failed within 6 months of a normal surveillance examination. GFV measurements less than 45 cm/sec in 99 grafts led to arteriography in 75 grafts, identifying 50 stenotic lesions in 48 bypasses (12.6% of series). Inflow lesions were present in 5%, outflow stenoses in 2%, and intrinsic graft stenoses in only 6% of bypasses. Only 29% of grafts identified as failing by duplex scan were associated with a reduction in ankle-brachial index of greater than 0.15. Secondary reconstructions were performed in 48 grafts based on detection of a reduced GFV measurement; all such reconstructions are patent after a mean follow-up of 5 months. Duplex surveillance is more reliable in identification of failing vein grafts than is determination of ankle-brachial index.

In the past 7 years, we have encountered six patients with finger ischemia as a result of digital artery occlusion associated with seven distal ulnar artery aneurysms. Our experience with the management of these patients forms the basis of this report. All patients were men, with a mean age of 29 years, and all experienced repetitive trauma to the involved upper extremity. Each patient presented with the acute onset of cool and painful digits, with no previous history of cold sensitivity or Raynaud's syndrome. None of the patients had any serologic or clinical evidence of autoimmune disease. Angiography revealed occlusion of the ulnar artery on the affected side in two patients and patent ulnar artery aneurysms in the remaining five patients. There was occlusion of multiple common and proper digital arteries in all patients. One patient with bilateral ulnar artery aneurysms underwent operative repair consisting of aneurysm excision and replacement with autogenous vein grafts from the lower extremity. All patients have improved symptoms, and the grafts remained patent over a mean follow-up of 24 months (range: 13 to 57 months). Based on these results, we recommend that excision and grafting be considered for patients with symptomatic patent ulnar artery aneurysms. Selected patients with thrombosed aneurysms with ongoing digital ischemia may also benefit from surgical intervention.

Objectives To review the occurrence of mycotic aneurysm affecting upper extremity arteries. Design Literature review. Materials and methods A MEDLINE search from 1950 until 2007 and an extensive manual search were carried out using bibliographies from relevant published papers including cases involving arteries distal to the subclavian. Results A total of 149 cases (68 papers) were identified. The brachial artery was the most frequently reported site, mostly associated with drug abuse, catheterization procedures or endocarditis. Since 1950 arterial trauma (drug abuse or catheterization) was the commonest cause. Gram positive organisms were the most frequent microbes involved. Acknowledging a limited follow-up, most patients did well when surgical therapy was promptly instituted. Conclusions Infected upper extremity aneurysms have been rarely described. IV drug abusers are a unique high-risk group for mycotic aneurysms in the upper extremities, most importantly in the axillary and brachial arteries. When rapidly performed, arterial ligation, primary repair or reconstruction with autogenous conduits was associated with favorable outcomes.

Purpose To review the pathogenesis, diagnosis, presentation, diagnosis, management and outcomes (morbidity and mortality) of superficial femoral artery aneurysms. Methods A comprehensive review of this entity was performed based on the available literature in all languages and a detailed discussion of our findings is also provided. Results Our review identified 61 cases of SFA aneurysms. They were most often seen in elderly men, predominately affected the right lower extremity, and were most often located in the middle-third of the artery. At the time of diagnosis, SFA aneurysms were frequently symptomatic because they reached a relative large diameter before the diagnosis was made. The most frequent presentation was localized pain in association with a pulsatile mass. In contrast to popliteal aneurysms, SFA aneurysms more frequently present with rupture than distal ischemia. Angiography was by far the most commonly utilized diagnostic tool. Treatment was primarily by means of an interposition graft, followed by exclusion and surgical bypass. Endovascular repair of SFA aneurysms has only been reported in three instances. SFA aneurysm repair was most often associated with favorable outcomes, with low reported rates of ischemia and limb loss.

Critical limb ischemia (CLI) is the most severe manifestation of peripheral artery disease (PAD). Without timely recognition, appropriate diagnosis, and revascularization, patients with CLI are at risk for amputation or potentially fatal complications. The past decade has seen substantial growth in endovascular CLI therapies and options now exist for treating long-segment lower-extremity arterial occlusive disease, but surgical bypass may yield more durable results. Patients who are younger, more active, and at low risk for surgery may have better outcomes with an operation. Surgical treatment is also indicated for failures of endovascular therapy, which may include early technical failures or later occlusion after placement of stents or other interventions.

Aneurysms involving the infrapopliteal arteries are rare, with most cases being attributed to a previous traumatic event. Mycotic aneurysms in this location are even more uncommon. Owing to their infrequency, these aneurysms represent a difficult diagnostic challenge. We present a case of a symptomatic anterior tibial artery aneurysm in a 59-year-old male with a medical history significant only for an episode of bacterial endocarditis, subsequently requiring an aortic valve replacement. Surgical repair was performed with a popliteal to anterior tibial bypass with a reversed saphenous vein graft. The patient's recovery was uneventful. We also reviewed the literature on this type of aneurysm to assess the incidence, etiology, options for treatment, and outcomes.

Background Aortic graft-colonic fistulae are a rare complication of aortic reconstructive surgery. Methods and findings A comprehensive review of this entity was performed based on the available literature from 1950 until 2006. Available reports were analyzed with respect to demographics, prior surgical intervention and its indication, prosthetic material used during the initial intervention, clinical presentation, the time interval in between the initial operation and symptoms, the method of treatment of the aortic graft-colonic fistula and its outcome.

Outcome analysis is increasingly being used to develop health-care policy and direct patient referral. For example, the Leapfrog Group health-care quality initiative has proposed "evidence-based hospital" referral criteria for specific procedures including elective abdominal aortic aneurysm repair (AAA-R). These criteria include an annual hospital AAA operative volume exceeding 50 cases and provision of intensive care unit (ICU) care by board-certified intensivists. Outcomes after AAA-R are reportedly influenced by presentation (intact vs. ruptured), operative approach (endovascular vs. open, transperitoneal vs. retroperitoneal), surgeon subspecialty, case volume (hospital and surgeon), and provision of postoperative care by an intensivist. The purpose of this study was to compare our single-center results with those of high-volume centers to assess the validity of the concept that surrogate markers, such as case volume or intensivist involvement, can be used to estimate procedural outcome. A retrospective review was performed of AAA-Rs at one low-volume academic medical center from January 1994 to March 2005. Demographic data, aneurysm diameter and location, operative indications, and repair approach were documented. Postoperative complications, mortality rates, and hospital and ICU length of stay (LOS) were noted and compared to established benchmarks. During the study period, 270 patients underwent AAA-R (annual mean = 27 hospital cases and 13.4 cases/attending vascular surgeon). ICU care was provided by a dedicated vascular surgery service without routine intensivist involvement. Open, elective, infrarenal AAA-R was performed in 161 patients (60%), with a 2.5% hospital mortality rate (30-day, 3.1%). Thirty-three (12%) patients underwent elective endovascular aneurysm repair (EVAR), with no mortality. Both ICU (3.7 vs. 1.4 days, p = 0.03) and hospital (9.2 vs. 2.8 days, p = 0.002) LOS were significantly reduced after EVAR compared to open repair. Hospital LOS was significantly lower after open retroperitoneal repair compared to transperitoneal repair (6.1 vs. 10.3 days, p = 0.001). Thirty-five patients (13%) underwent ruptured AAA-R, with only 34.3% mortality (in-hospital and 30-day). Forty-one patients (15%) underwent repair of complex aortic aneurysms, with 14.1% mortality. There are increasing societal and economic pressures to direct patient referrals to "centers of excellence" for specific surgical procedures. Although our institution meets neither of the Leapfrog Group's proposed criteria, our mortality and LOS for both intact and ruptured infrarenal AAA-R are equivalent or superior to published benchmarks for high-volume hospitals. Individual institutional outcome results such as these suggest that patient referral and care should be based upon actual, carefully verified outcome data rather than utilization of surrogate markers such as case volume and subspecialist involvement in postoperative care.

At the present time, infrainguinal bypass using autogenous vein is the most effective and durable treatment for chronic limb ischemia caused by long-segment, diffuse, atherosclerotic occlusive disease. Quality of the vein conduit is the most important factor that determines operative success. Preoperative vein mapping is useful to identify an optimal vein conduit as well as to suggest vein segments that should not be explored due to occlusion, significant calcification, poor caliber, or sclerosis. Reversed, nonreversed, and in situ vein bypass grafts all perform equally well, and the choice of technique depends on anatomic considerations and surgeon preference. Bypass grafts originating from inflow sources distal to the common femoral artery may be appropriate in selected cases without compromising graft patency. All vein graft patients should be followed by postoperative, duplex-based graft surveillance. Antiplatelet therapy is indicated in all infrainguinal bypass patients; oral anticoagulation may be worthwhile in selected, high-risk patients, but hemorrhagic risks are significantly increased.

The goal of this manuscript is to suggest the utilization of pre-existing population data to provide a functional tool for health systems and administrators to best estimate and plan resource utilization when building or refining a diabetic foot clinic. The system allows one to predict the number of expected risk-category specific visits from a local community in a given year. It is our hope that this system will aid health care providers in administrative planning and overhead. The calculator is hosted at http://www.diabeticcalculator.com as a free to use operation.

Purpose Gadolinium-enhanced magnetic resonance angiography (MRA) is commonly used as a screening modality for the detection of renal artery stenosis. However, evidence supporting its utility in clinical practice is lacking; few rigorous studies have compared MRA with contrast arteriography (CA). After making anecdotal clinical observations that MRA sometimes overestimated the degree of renal artery stenosis, we decided to determine the interobserver variability, sensitivity, specificity, and diagnostic accuracy of MRA compared with CA. Methods From September 1999 to April 2003, we evaluated 68 renal arteries in 34 patients with clinically suspected renal artery stenosis using both MRA and CA. All studies were independently reviewed by four blinded observers. Renal arteries were categorized by MRA as normal, 50% stenosis/occlusion. The sensitivity, specificity, and accuracy of MRA detection of renal artery stenosis were compared to CA as the gold standard. Interobserver variability (κ) was also calculated. Results MRA demonstrated 87% sensitivity, 69% specificity, 85% accuracy, 95% negative predictive value, and 51% positive predictive value for the diagnosis of renal artery stenosis. Interobserver agreement was moderate for MRA (κ = 0.53) and good for CA (κ = 0.76). In 21 arteries (31%), MRA was falsely positive. Conclusions In patients with a high clinical suspicion of renal artery stenosis, MRA is 87% sensitive in the detection of >50% stenosis. However, MRA is relatively nonspecific compared with CA and results in significant overestimation of renal artery stenosis in nearly one third of patients. To reduce unnecessary CA, clinicians should consider supplemental studies.

Although an axiom of wound care is to achieve speedy, durable healing, there exists a small, but persistent, subset of patients for whom a more practical and achievable goal might not necessarily be to heal the wound, but rather to prevent its escalation. Similarly, there are patients with very large or complex wounds that may take months or even years to completely heal or may recur despite robust prevention efforts. When confronting such problematic conditions across the broad spectrum of a wound care practice, current definitions of success in wound repair are impractical and not universally applicable. We suggest that in certain clinical scenarios it might be worthwhile to redefine success based on achievable patient-oriented outcomes. We offer seven criteria that may categorize the patient who is in a “wound simplification” category. These include: (1) the wound is painless or minimally painful; (2) the patient's functional capacity is stable, without requiring increased assistance from baseline, and has not deteriorated secondary to ongoing treatment of the wound; (3) the patient or a non-medical family member can perform dressing changes him/herself; (4) the patient requires no more than two visits to the doctor per month; (5) the wound has neither significantly increased in area (

Wound classification systems have evolved from linear systems describing only one factor to more matrix-oriented, allowing wider clinical applicability. We suggest that, in a similar fashion to wound classification, a flexible long-term management philosophy should be dynamic and conceptually inclusive. We visualize amputation prevention as the management of three partially intersecting rings whose complex interplay competes for dominance at any given time during the life of the patient and his or her limb. These rings of dominance involve tissue loss, ischemia, and infection and are constantly in motion. Once a patient has a wound or has healed a wound, one might consider this flexible approach to management and assessment. A question that might be asked would be: “At this moment, which ring does this patient's biggest problem lie? Infection? Ischemia? Tissue Loss? Combinations?” This approach may help the interdisciplinary team understand who is primarily responsible for care at any given time while understanding the dynamic nature of management of the high-risk patient.

Because neuroischemic complications are associated with a high rate of recurrence, we propose a slight shift in the mechanism by which we counsel and communicate risk daily with our patients. If the epidemiology of this problem is comparable with that of cancer, and recurrences are common, then perhaps language commensurate with such risks should follow. After initial healing of an index wound, our unit now refers to patients not as being cured but rather as being “in remission.” This concept is easy for the patient and the rest of the team to understand. We believe that it powerfully connotes the necessity for frequent follow-up and rapid intervention for inevitable minor and sometimes major complications. (J Am Podiatr Med Assoc 103(2): 161–162, 2013)

The purpose of these guidelines is to the summarize consensus of a multidisciplinary expert advisory panel convened to determine appropriate use of negative pressure wound therapy (NPWT), also known as Vacuum-Assisted Closure or V.A.C. Therapy, in the treatment of diabetic foot wounds. The Tucson Expert Consensus Conference (TECC) on V.A.C. Therapy was convened in an effort to guide the direction for future research either to confirm or refute current consensus while providing practical guidance to the clinician currently treating diabetic foot wounds. The consensus committee discussed and commented on the following ten key questions regarding NPWT: 1) How long should NPWT be used in the treatment of a diabetic foot wound? 2) Should NPWT be applied to a wound that has not been debrided? 3) How should the patient using NPWT be evaluated on an outpatient basis? 4) When should NPWT be applied following lower-extremity bypass? 5) When should NPWT be applied after incision and drainage of infection? 6) How should NPWT be used in patients with osteomyelitis? 7) How should nonadherence (i.e., noncompliance) be defined in the patient on NPWT? When should NPWT be discontinued in this population? 8) How should NPWT be used in combination with other modalities? 9) Should small, superficial, noninfected wounds be considered for NPWT? 10) How should we define success in future studies of NPWT?

Background Graft patency, limb salvage, and mortality are the traditional means of assessing the outcome of infrainguinal bypass surgery (IBS). However, these measures underestimate patient morbidity and fail to consider the entire spectrum of treatment required to restore the patients to their premorbid state. The aim of this study was to quantify the efforts required to achieve limb salvage by assessing three nontraditional outcomes: (1) index limb reoperation rate in 3 months, (2) hospital readmission rate in the first 6 months after IBS, and (3) wound-healing time. Methods We retrospectively analyzed 318 IBSs performed at a single institution. Repeat operations for limb or graft-related problems and readmissions within 6 months of the initial operation were recorded. When available, wound-healing time was determined. Pertinent demographics and comorbidities were subjected to univariate and multivariate analysis to determine risk factors for adverse outcomes. Results Seventy-two percent of patients underwent IBS for critical limb ischemia (CLI), and 84% had below-knee popliteal or distal bypasses. Among those who underwent IBS for CLI, 48.9% of patients required at least one reoperation within 3 months. Within 6 months, 49.3% of patients required hospital readmission. Time to heal exceeded 3 months in 54% of patients. After multivariate analysis, tissue loss and minority status were significant risk factors for reoperation within 3 months. Tissue loss and renal failure increased the odds for readmission within 6 months. Diabetes was the sole risk factor for prolonged wound healing. Conclusions IBS for limb salvage is often complicated by prolonged recovery and multiple reoperations and readmissions. Traditional reporting standards for limb salvage operations need modification to reflect the true outcome of such procedures.

Purpose: The typical leg bypass surveillance program begins with a duplex scan evaluation of the vein graft 3 months after surgery; studies are repeated every 3 months during the first year of follow-up and are fully reimbursed by our Medicare carrier. Some authors have recommended early (before discharge or first postoperative visit) duplex scanning to identify high-risk grafts. However, the natural history of velocity disturbances detected with early scans is unclear, and furthermore, such studies are not reimbursed by Medicare. Methods: We reviewed all infrainguinal vein bypass grafts prospectively entered into a surveillance protocol that included an early (200 cm/s) in 58 grafts (26%). Six grafts of the 58 (10.3%; 2.7%) with an early abnormal duplex scan and unrepaired defects occluded during the follow-up period. Thirty grafts were revised on the basis of the initial early scan; 23 of these revisions were performed for critical or rapidly progressive lesions in the first 3 postoperative months. Seven lesions progressed more slowly and were repaired at a mean of 8 months after surgery. Interestingly, 22 flow abnormalities (37%) resolved or stabilized despite a PSV of more than 300 cm/s in six cases (27%). Clear duplex scan evidence of regression or progression of these early flow abnormalities occurred within 3 months in 51/58 cases (88%). A total of 68 grafts (30%) were revised during the entire study period; 30 of these (44%) were on the basis of the early abnormal scan. Conclusion: Despite normal completion arteriography, early graft velocity abnormalities are strikingly common and were detected in 26% of the 224 infrainguinal vein grafts in this series. These lesions were clinically important because 52% necessitated revision. Surprisingly, however, 38% of these early flow disturbances resolved, despite a PSV of more than 300 cm/s in 27% of cases. Early duplex scan surveillance singularly detects a clinically significant subgroup of grafts that need revision. The possible origin of these early lesions deserves further inquiry, but on the basis of its clinical yield, we recommend that early duplex scan surveillance of infrainguinal bypass grafts should be routine and should be considered for Medicare reimbursement. (J Vasc Surg 2003;37:495-500.)

Objective: The purpose of this study was to evaluate graft patency and limb salvage rates for infrainguinal polytetrafluoroethylene (PTFE) bypass grafts using distal anastomotic Taylor vein patch in patients lacking suitable vein conduit. Methods: We reviewed 44 patients who underwent infrainguinal bypass between January 1996 and August 2000 using 6-mm PTFE and a distal Taylor vein patch. Postoperative oral anticoagulation was administered to 80% of patients. Graft patency was confirmed during follow-up with serial graft duplex scanning. Results: Operative indications were rest pain, nonhealing ulcer, or gangrene in 76% of patients, 43% of whom had undergone previous ipsilateral leg bypass. Distal anastomotic sites were the below-knee popliteal (29%) and tibial-peroneal arteries (67%). At 1 month, 1 year, and 2 years, respectively, the primary patencies (SE

Horner's syndrome is described in a patient with anisocoria and unilateral lid ptosis 48 hours after an ipsilateral carotid endarterectomy. This case illustrates a rare iatrogenic complication of sympathetic nerve dysfunction following elective surgery.

Graft surveillance has evolved over the last 15 years into a useful clinical tool designed to reduce the incidence of lower extremity vein bypass graft occlusion. Graft surveillance has not been shown to be efficacious in improving patency of prosthetic leg bypasses. However, the most common cause of infrainguinal vein graft occlusion is intrinsic graft stenosis. Vein graft lesions, or flow disturbances, develop in approximately one third of lower extremity autogenous vein grafts. These lesions frequently progress and ultimately are responsible for 60% to 80% of all vein graft occlusions. Surveillance protocols allow the vascular surgeon to identify such graft-threatening lesions and monitor them for progression, stabilization, or resolution based on measurements of peak systolic flow velocity, velocity ratio, end-diastolic velocity, and other simple hemodynamic parameters. There is a substantial body of clinical evidence, and a single prospective, randomized trial that suggest that lower extremity graft surveillance is clinically useful, cost effective, and likely improves long-term graft patency and limb salvage rates by 10% to 15%.

Purpose. Preimplant vein morphology has been implicated as a risk factor for subsequent vein graft failure. It is controversial whether microscopic intimal thickening in random saphenous vein biopsy specimens is associated with an increased risk of graft failure. The purpose of this study was to determine the incidence of preexisting intimal thickening in a macroscopically normal preimplant vein, and to evaluate whether preimplant vein intimal thickness was predictive of future vein graft stenosis. Methods. As part of an ongoing protocol, samples of preimplant veins were obtained at the time of the primary leg bypass. Routine duplex surveillance identified 14 patients who required operative revision for severe graft stenosis ( n = 12) or graft occlusion ( n = 2). Verhoeff's staining of specimens was performed to delineate the internal elastic lamina. Morphometric analysis of preimplant vein specimens was performed. The results were compared to a control group of 13 preimplant vein specimens selected from patients whose grafts have remained patent and stenosis-free by duplex. Results. Preoperative risk factors were identical between the two groups. Mean intimal thickness in all 27 specimens was measured by two blinded observers. Almost 50% of specimens exhibited marked intimal thickening (>0.08 mm). The mean preimplant intimal thickness of the stenosis group was 0.108 mm ± 0.155 compared to 0.100 mm ± 0.064 for the control group ( P = 0.866, NS). Conclusion. Although grossly normal preimplant veins often exhibit prominent microscopic intimal thickening, preimplant vein intimal thickness determined from a random saphenous vein biopsy at the time of primary leg bypass is not predictive to the subsequent development of vein graft stenosis.

PURPOSE: Modified anastomotic techniques utilizing autogenous vein-cuffs or patches have been devised with the hope of improving prosthetic graft patency. The mechanisms of the presumed improvement in patched anastomoses have never been elucidated and remain speculative. We characterized the healing response of the Taylor vein patch in prosthetic arteriovenous fistulae in a canine model of intimal hyperplasia. METHODS: Six adult dogs underwent placement of bilateral (6 patched, 6 control) 4-mm diameter expanded polytetrafluoroethylene loop femoral artery-vein fistulae. Serial duplex ultrasound examinations confirmed graft patency until explant at 6 weeks. Differential light microscopy with computerized image analysis was performed on serial 5-mm sections. Intimal thickness through the venous anastomosis and outflow veins of Taylor patch and control (nonpatched) grafts were compared. Cell type-specific immunocytochemical antibody stains for smooth muscle cells (a SMC actin) and endothelial cells (von Willebrand factor) were performed. RESULTS: Eleven of 12 grafts remained patent for 6 weeks, 1 control graft thrombosed. Mean duplex-derived peak systolic velocities of patched (96 cm/sec) and control (108 cm/sec) grafts were similar. Microscopy revealed more intimal pannus anastomotic suture line ingrowth in controls (mean thickness 5 178 mm) than Taylor patched grafts (mean 147 mm, p 5 0.0002). Significantly less intimal thickening was present in the outflow vein of patched (mean thickness 5 90 mm) versus control grafts (mean 195 mm, P

Purpose: It has been proposed that inferior vena cava filter placement should be the initial treatment of deep venous thrombosis (DVT) or pulmonary embolus (PE) in patients with coexisting malignant disease. We have chosen instead to selectively place filters only in patients with either a contraindication to anticoagulation therapy or a subsequent complication from anticoagulation therapy. The treatment efficacy and mortality rates in patients with concomitant malignant disease and venous thromboembolism using this approach was determined. Methods: We retrospectively reviewed all patients at our institution with malignant disease in whom venous thromboembolism developed between August 1991 through August 1996 and identified 166 patients with PE (n = 8), DVT (n = 147), and DVT/PE (n = 11). Of these patients, 138 (83.1%) were initially treated with anticoagulation therapy, and 28 (16.9%) had primary filter placement because of contraindications to anticoagulation therapy (10 for intracranial tumors, 11 for recent or upcoming operations, 6 for recent hemorrhage, and 1 for a malignant bloody pericardial effusion). Results: Thirty-two (23%) of the 138 patients who initially underwent anticoagulation therapy subsequently required a filter for the following reasons: bleeding (n = 15, 10.9%); recurrent thromboembolism (n = 6, 4.3%); heparin-induced thrombocytopenia (n = 1, 0.7%); and perceived high risk for bleeding with continued anticoagulation therapy (n = 11, 8%). Both bleeding and recurrent thromboembolism developed in 1 patient. Sixty patients (36%) received filters. No major technical complications occurred from filter placement. Major recurrent thromboembolic complications developed in 10 patients: DVT (n = 6, 10%), PE (n = 2, 3.3%), inferior vena cava thrombosis and phlegmasia cerulea dolens (n = 1, 1.7%), superior vena cava thrombosis (n = 1, 1.7%). Venous gangrene developed in 1 patient with DVT. The 1-year actuarial survival rates for patients treated with filter and anticoagulation therapy were 35% and 38%, respectively ( P = NS). Conclusion: In summary, our experience suggests that 64% of patients with malignant disease and venous thromboembolism are effectively treated with anticoagulation alone; 17% require primary filter placement for standard indications, and an additional 19% require subsequent filter placement because of complications (primarily bleeding) or failure of anticoagulation therapy. Although technical complications of filter placement are low, serious life-threatening or limb-threatening thromboembolic complications developed in 17% of patients. Survival was poor in all patients, regardless of treatment. These data support a conservative approach of routine anticoagulation therapy with selective filter placement. (J Vasc Surg 1998;28:800-7.)

Purpose: Because the natural history of carotid body tumors is believed to be unpredictable, immediate surgical removal has been recommended. The present study reviews our experience in the diagnosis and treatment of these uncommon lesions. Methods: The medical records of patients who appeared for treatment with carotid body tumors between 1981 and 1997 were reviewed. Patients demographics, mode of presentation, imaging and treatment modalities, Shamblin classification, and neurologic complications (stroke, cranial nerve injuries) were analyzed. Results: Over the past 16 years, 31 patients with 32 carotid body tumors have been evaluated, with an average follow-up of 3.2 years. The patients were arbitrarily classified into two groups on the basis of the mode of detection. Seventy percent (23 of 32) of the tumors discovered on clinical or self-examination were classified as Group 1; 28% (9 of 32) of the tumors detected during duplex scanning for carotid artery disease (8) or MRI (1) were classified as Group 2. The mean size of chemodectomas found on palpation (4.3 ± 1.7 cm) was larger than that of those detected by duplex ultrasound (2.7 ± 1.0 cm; p < 0.05, by paired t test). Preoperative embolization was successfully performed in 5 of 6 instances of large tumors; the remaining patient suffered a procedure-related stroke. Thirty-one carotid body tumors were resected. In one case, the tumor was felt by the primary surgeon to be too small (0.9 × 0.7 cm on duplex scan) to warrant immediate excision; this patient is being followed by periodic duplex scanning. Five neurologic complications were noted in Group 1, one after preoperative embolization and four after surgery. One cranial nerve injury occurred in Group 2. One patient had a large recurrent chemodectoma with clinical evidence of metastatic disease. Conclusion: The increasing use of sophisticated imaging modalities may allow earlier discovery of carotid body tumors before they can be clinically detected. Resection of carotid body tumors of all sizes in appropriate surgical candidates remains the standard of care. Unfortunately, resection of even small tumors is associated with a low but constant incidence of neurologic complications. (J Vasc Surg 1998;28:84-93)

Background.Although smooth muscle cell proliferation is a prominent feature of restenosis in experimental models, the role of cellular proliferation in the initiation and progression of carotid restenosis is not well documented. Methods.Between 1985 and 1995, 35 carotid endarterectomies (CEA) in 34 patients were performed for restenosis. Patient risk factors, cerebrovascular symptoms, and operative findings were recorded. Tissue specimens from 29 of these cases and 14 original specimens from the same patient were examined by light microscopy (H&E, trichrome, elastochrome, and Alcian blue) and immunohistochemistry (α actin, CD 68, vWF, and proliferating nuclear cell antigen (PCNA)) in order to determine the morphologic characteristics and cellular proliferative activity of the plaque. Results.Hemodynamically significant recurrent stenosis occurred in the 29 patients (69% symptomatic) between 2 months and 30 years after their initial CEAs. Eleven of 29 (38%) lesions were removed early (

Critical limb ischemia, first defined in 1982, was intended to delineate a subgroup of patients with a threatened lower extremity primarily because of chronic ischemia. It was the intent of the original authors that patients with diabetes be excluded or analyzed separately. The Fontaine and Rutherford Systems have been used to classify risk of amputation and likelihood of benefit from revascularization by subcategorizing patients into two groups: ischemic rest pain and tissue loss. Due to demographic shifts over the last 40 years, especially a dramatic rise in the incidence of diabetes mellitus and rapidly expanding techniques of revascularization, it has become increasingly difficult to perform meaningful outcomes analysis for patients with threatened limbs using these existing classification systems. Particularly in patients with diabetes, limb threat is part of a broad disease spectrum. Perfusion is only one determinant of outcome; wound extent and the presence and severity of infection also greatly impact the threat to a limb. Therefore, the Society for Vascular Surgery Lower Extremity Guidelines Committee undertook the task of creating a new classification of the threatened lower extremity that reflects these important considerations. We term this new framework, the Society for Vascular Surgery Lower Extremity Threatened Limb Classification System. Risk stratification is based on three major factors that impact amputation risk and clinical management: Wound, Ischemia, and foot Infection (WIfI). The implementation of this classification system is intended to permit more meaningful analysis of outcomes for various forms of therapy in this challenging, but heterogeneous population.

We report the case of a 71-year-old man who had interval gangrene of his calf with subsequent vein graft blowout 3 months after undergoing a femoral–to–dorsalis pedis saphenous vein bypass grafting procedure. To provide wound coverage, restore vascular continuity, and preserve functional ambulation, a flow-through radial forearm fasciocutaneous free flap was interposed between cut ends of the bypass graft. Venous drainage of the flap was from the cephalic vein to the popliteal vein. At 1 month after the operation, the patient had complete wound healing and began to ambulate. At 11 months an asymptomatic high-grade stenosis in the distal radial artery segment of the reconstruction was successfully treated with percutaneous angioplasty. After 22 months of follow-up there have been no further complications, and the patient continues to have full, functional ambulation. The radial forearm flow-through free flap allows single-stage restoration of bypass graft continuity and coverage of extensive, complex tissue defects. This technique represents a novel approach to this difficult problem and provides a viable alternative to major limb amputation. (J Vasc Surg 1997;26:711-4.)

The cause of intrinsic vein graft stenosis, which develops in at least 20% of infrainguinal autogenous bypass grafts during the intermediate follow-up interval, is unknown. We performed standard duplex surveillance of all lower extremity bypass grafts and evaluated the potential of comorbid patient risk factors that might predict development of vein graft flow disturbance or high-grade graft stenosis.Patients with at least 6 months of postoperative duplex surveillance were identified through our vascular registry. The association of clinical and hemodynamic profiles of graft performance were compared with specific patient risk factors, including demographics, cigarette smoking, antihypertensive medical therapy, type and quality of conduit, degree of ischemia, bypass run-off, and presence of infection, using stepwise logistic regression analysis.Ninety-three patients (55 male, 38 female; mean age 69) underwent 100 infrainguinal bypasses. Twenty-six high-grade graft stenoses (70%) were identified in 26 patients during follow-up (mean 21 months) by graft-flow peak systolic velocity (PSV)300 cm/sec on more than one duplex examination, and were electively revised. Graft flow disturbances (180 cm/secPSV300 cm/sec) were identified in an additional 13 grafts (6 regressed, 7 observed). The need for graft revision was associated with an early graft flow disturbance (P = 0.02), or drop in ankle-brachial index0.15 (P = 0.03), and the use of an alternative conduit in 13 of 100 grafts (P = 0.04). Only smoking was associated with the development of a duplex detected graft flow disturbance during follow up (P = 0.03).Grafts with early flow disturbances warrant close duplex surveillance to identify graft-threatening stenosis. Risk factors that may predict future lower extremity bypass graft stenosis are smoking and the use of alternative bypass conduits.

Although color flow duplex surveillance (CFDS) of infrainguinal vein grafts has gained wide acceptance, definitive criteria mandating graft revision remain to be established. We prospectively evaluated 101 infrainguinal vein grafts undergoing CFDS in order to validate threshold duplex criteria for intervention which were derived from our previous experience and that reported by others. Complete CFDS of the bypass conduit and adjacent inflow and outflow arteries and Doppler-derived ankle brachial indices (ABI) were obtained every 3 months x 4 and every 6 months thereafter. The following threshold criteria mandating further evaluation and intervention to prevent graft occlusion were applied: high-velocity criteria (HVC) defined as peak systolic velocity (PSV)300 cm/sec and velocity ratio (Vr)3.5; low-velocity criteria (LVC) defined as PSV45 cm/sec; an ABI decrease0.15. Fifty-one grafts had normal serial CFDS and ABI; none subsequently occluded or required revision. Stenosis was detected by CFDS in 43 grafts (PSV180 cm/sec, Vr1.5). Within this subgroup, 54% of grafts subsequently required revision (20/43) or occluded (3/43). All grafts in this subgroup with stenoses progressed to PSV300 or Vr3.5 prior to revision or occlusion. Ten lesions (23%) regressed spontaneously without intervention (mean PSV 252 cm/sec, mean Vr 3.2); 10 lesions (23%) are stable, non-progressive, and remain under surveillance. Two grafts were abnormal by LVC; one was successfully revised, the other occluded prior to intervention. Five grafts had normal CFDS and ABI decrease0.15. Four were revised (three inflow lesions, one outflow lesion) and one occluded (missed lesion by CFDS). Only five graft occlusions occurred in the entire series: three grafts met HVC and occluded prior to intervention; one developed an ABI drop of 0.4 due to graft stenosis missed by CFDS and uncovered following thrombolysis, and the other graft met LVC and occluded prior to intervention. Infrainguinal vein grafts with normal serial CFDS and ABI are at minimal risk of spontaneous graft occlusion. When CFDS is abnormal (PSV180 cm/sec, Vr1.5), over 50% of grafts will ultimately require revision or progress to occlusion. Grafts with such lesions can be safely monitored by CFDS until progression to lesions meeting HVC occurs with minimal risk of graft occlusion. A decrease in ABI0.15 with normal CFDS mandates arteriography to identify inflow and outflow lesions or a missed graft stenosis. The present study prospectively validates threshold intervention criteria for graft lesions meeting HVC (PSV300 cm/sec, Vr3.5), LVC (PSV45 cm/sec throughout graft) or an ABI decrease0.15.

The authors studied the results of a randomized controlled trial in which patients who underwent percutaneous transluminal angioplasty either received centered endovascular gamma irradiation or were in a control group. Patients were evaluated at various time-points with intra-arterial angiography, duplex ultrasonography, treadmill tests, and were also interviewed and the results were analyzed. At baseline the two groups had similar characteristics. The rates of target lesion restenosis at 6 and 12 months were significantly lower in the irradiation group. The authors concluded that patients who had endovascular irradiation after angioplasty of de novo femoropopliteal stenosis had a significantly reduced degree of stenosis at 6 and 12. Target vessel retreatment was more frequent in the irradiation group.